Panzyga approved in U.S. for chronic inflammatory demyelinating polyneuropathy Feb. 15, 2021 No Comments
FDA approves Cosela for myeloprotection in patients with extensive-stage SCLC receiving chemotherapy Feb. 15, 2021 No Comments
FDA grants EUA for etesevimab and bamlanivimab for mild to moderate COVID-19 Feb. 10, 2021 No Comments
FDA grants accelerated approvals of Ukoniq for marginal zone lymphoma and follicular lymphoma Feb. 8, 2021 No Comments
Korean MFDS grants conditional marketing authorization for Regkirona for COVID-19 Feb. 8, 2021 No Comments
FDA grants accelerated approval to Tepmetko for metastatic NSCLC with METex14 skipping alterations Feb. 4, 2021 No Comments
RSS